Molecule Information
General Information of the Molecule (ID: Mol02198)
Name |
SIRT1 antisense RNA (SIRT1-AS)
,Homo sapiens
|
||||
---|---|---|---|---|---|
Synonyms |
SIRT1-AS
Click to Show/Hide
|
||||
Molecule Type |
LncRNA
|
||||
Gene Name |
SIRT1-AS
|
||||
Gene ID | |||||
HGNC ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
EADR: Epigenetic Alteration of DNA, RNA or Protein
Drug Resistance Data Categorized by Drug
Investigative Drug(s)
1 drug(s) in total
Astragaloside IV
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Epigenetic Alteration of DNA, RNA or Protein (EADR) | ||||
Disease Class: Pulmonary fibrosis | [1] | |||
Resistant Disease | Pulmonary fibrosis [ICD-11: CB03.1] | |||
Resistant Drug | Astragaloside IV | |||
Molecule Alteration | Down-regulation | Expression |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | RLE-6TN cells | Lung | Rattus norvegicus (Rat) | CVCL_4693 |
Experiment for Molecule Alteration |
Overexpression assay; Knockdown assay | |||
Experiment for Drug Resistance |
CCK8 assay | |||
Mechanism Description | Collectively, sirt1 AS was critical for ASV-mediated inhibition of IPF progression and targeting of sirt1 AS by ASV could be a potential therapeutic approach for IPF. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.